NRC — Human Health Therapeutics Research Centre

For biotech and life sciences organizations working to bring new therapies from concept to clinic, access to specialized expertise and infrastructure can be just as critical as capital. The NRC — Human Health Therapeutics Research Centre offers Canadian businesses and research organizations a way to tap into advanced scientific capabilities that would be difficult or costly to build in-house. Delivered by the National Research Council Canada, this initiative supports human health therapeutics projects across the country, from early discovery through to clinical-scale production.

The program is especially relevant for companies developing biologics, including vaccines, cell and gene therapies, and treatments targeting complex conditions such as cancer, neurological disorders, and emerging infectious diseases. Participants can collaborate directly with NRC scientists and access leading-edge laboratories, proprietary cell lines, vectors, and manufacturing facilities. Support may include preclinical testing, bioprocess development, scale-up work, and the production of clinical trial material under good manufacturing practices. Advisory services and potential licensing opportunities further help organizations strengthen their development and commercialization pathways.

Rather than a fixed grant amount, support is tailored to each project and focused on accelerating R&D outcomes through hands-on collaboration and technical resources. Startups, established companies, and nonprofits in the biotechnology and healthcare space that meet certain requirements may benefit from this national program. Exploring the full scope of services and collaboration options can help determine how this research centre aligns with your therapeutic development goals.